We are live on ! Find out more
Voloridge Investment Management

Voloridge Investment Management Portfolio holdings

AUM $25B
1-Year Est. Return 28.08%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
Cap. Flow
+$224M
Cap. Flow %
1.06%
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$211M
2
ABBV icon
AbbVie
ABBV
+$176M
3
AAPL icon
Apple
AAPL
+$170M
4
NKE icon
Nike
NKE
+$161M
5
KO icon
Coca-Cola
KO
+$141M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$221M
2
MDT icon
Medtronic
MDT
+$163M
3
UNH icon
UnitedHealth
UNH
+$148M
4
JNJ icon
Johnson & Johnson
JNJ
+$133M
5
PFE icon
Pfizer
PFE
+$126M

Sector Composition

Rank Sector Weight
1 Technology 21.66%
2 Consumer Discretionary 14.98%
3 Healthcare 13.91%
4 Financials 10.93%
5 Industrials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLK
1326
DELISTED
Allakos
ALLK
$97K ﹤0.01%
22,253
-330,892
-94% -$1.49M
BLDP
1327
Ballard Power Systems
BLDP
$790M
$77.2K ﹤0.01%
17,696
-184,812
-91% -$842K
SPCE icon
1328
Virgin Galactic
SPCE
$475M
$48.9K ﹤0.01%
+631
New +$50K
ABNB icon
1329
Airbnb
ABNB
$111B
-211,584
Closed -$26.3M
ACIW icon
1330
ACI Worldwide
ACIW
$5.42B
-71,054
Closed -$1.92M
ACN icon
1331
Accenture
ACN
$109B
-772,915
Closed -$221M
ACRS icon
1332
Aclaris Therapeutics
ACRS
$863M
-11,349
Closed -$91.8K
ADBE icon
1333
Adobe
ADBE
$108B
-169,697
Closed -$65.4M
ADEA icon
1334
Adeia
ADEA
$3.16B
-168,484
Closed -$1.49M
ADNT icon
1335
Adient
ADNT
$1.54B
-39,607
Closed -$1.62M
ADT icon
1336
ADT
ADT
$5.46B
-17,729
Closed -$128K
AFL icon
1337
Aflac
AFL
$60.7B
-172,414
Closed -$11.1M
AFRM icon
1338
Affirm
AFRM
$26.2B
-11,916
Closed -$134K
AIG icon
1339
American International
AIG
$39.8B
-366,470
Closed -$18.5M
AKRO
1340
DELISTED
Akero Therapeutics
AKRO
-84,907
Closed -$3.25M
ALLE icon
1341
Allegion
ALLE
$14.2B
-10,322
Closed -$1.1M
ALSN icon
1342
Allison Transmission
ALSN
$10.2B
-12,403
Closed -$561K
AMG icon
1343
Affiliated Managers Group
AMG
$9.7B
-25,313
Closed -$3.61M
AMZN icon
1344
Amazon
AMZN
$2.86T
-253,645
Closed -$26.2M
ANET icon
1345
Arista Networks
ANET
$257B
-512,204
Closed -$21.5M
APD icon
1346
Air Products & Chemicals
APD
$68B
-54,603
Closed -$15.7M
APG icon
1347
APi Group
APG
$18.8B
-53,576
Closed -$803K
APTV icon
1348
Aptiv
APTV
$10.2B
-54,198
Closed -$6.08M
ARCB icon
1349
ArcBest
ARCB
$3.28B
-23,883
Closed -$2.21M
ARHS icon
1350
Arhaus
ARHS
$1.37B
-285,140
Closed -$2.36M

Similar funds

Voloridge Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
  • Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
  • Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
  • Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
  • Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
  • Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
  • Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.

Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.